Giuseppe Toffoli

Overexpression of folate binding protein in ovarian cancers

Giuseppe Toffoli, C. Cernigoi, Antonio Russo et al. · International Journal of Cancer · 1997 · 524 citations · Full text

Medicine, Oncology, Pathology +17

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

Giuseppe Toffoli, Erika Cecchin, Giuseppe Corona et al. · Journal of Clinical Oncology · 2006 · 337 citations · Full text

Medicine, Oncology, Pharmacology +17

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Cathelijne H. van der Wouden, Anne Cambon‐Thomsen, Erika Cecchin et al. · Clinical Pharmacology & Therapeutics · 2016 · 292 citations · Full text

Medicine, Pharmacoeconomics, Pharmacology +16

Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models

Mohamad Hadla, Stefano Palazzolo, Giuseppe Corona et al. · Nanomedicine · 2016 · 279 citations · Full text

Medicine, Oncology, Pharmacology +17